Antihypertensive Effects of Two Novel Angiotensin I-Converting Enzyme (ACE) Inhibitory Peptides from Gracilariopsis lemaneiformis (Rhodophyta) in Spontaneously Hypertensive Rats (SHRs)
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
A variety of biologically active products have been isolated from Gracilariopsis lemaneiformis. In the present study, two novel angiotensin-converting enzyme (ACE) inhibitory peptides, FQIN [M(O)] CILR, and TGAPCR, were screened and identified from G. lemaneiformis protein hydrolysates by LC-MS/MS. The IC50 values of FQIN [M(O)] CILR and TGAPCR were 9.64 ± 0.36 μM and 23.94 ± 0.82 μM, respectively. In the stability study, both peptides showed stabilities of pH, temperature, simulated gastrointestinal digestion, and ACE hydrolysis. The Lineweaver–Burk plot showed that the two peptides were noncompetitive inhibitors of ACE. Molecular docking simulated the intermolecular interactions of two peptides and ACE, and the two peptides formed hydrogen bonds with the active pockets of ACE. However, FQIN [M(O)] CILR was more closely linked to the active pockets of ACE, thereby exerting better ACE inhibition. Spontaneously hypertensive rats (SHRs) were studied with an oral dose of 10 mg/kg body weight. Both peptides reduced systolic blood pressure (SBP) and diastolic blood pressure (DBP) in SHRs, of which FQIN [M(O)] CILR was able to reduce the systolic blood pressure by 34 mmHg (SBP) (p < 0.05). Therefore, FQIN [M(O)] CILR was an excellent ACE inhibitory peptide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Temperature (a) and pH (b) stability of peptides FQIN [M(O)] CILR and TGAPCR. The concentration of peptides was 0.5 mg/mL; values represent mean ± SD (n = 3).](https://figures.cochat.ai/paper-figures/ba30ef28d00c46bc8e44519161422ec1/antihypertensive-effects-of-two-novel-angiotensin-i-converting-enzyme-ace-figure-1.jpg)
![Figure 2 Stability of FQIN [M(O)] CILR and TGAPCR under simulated gastrointestinal digestion. The final concentrations of peptides were 0.5 mg/mL (a) and 0.1 mg/mL (b), respectively. GC, peptide sample and simulated gastric fluid without pepsin; G, peptide sample with gastric fluid with pepsin; G + IC, peptide sample and simulated gastrointestinal fluid without pepsin and pancreatin; G + I, peptide sample with gastrointestinal fluid with pepsin and pancreatin. Values represent mean ± SD (n = 3).](https://figures.cochat.ai/paper-figures/314ba31eab80431381ed741d8d8acec4/antihypertensive-effects-of-two-novel-angiotensin-i-converting-enzyme-ace-figure-2.jpg)

![Figure 4 Lineweaver–Burk plots of ACE inhibited by the peptides. 1/V and 1/S represents the reciprocal of reaction velocity and substrate concentration, respectively. (a) FQIN [M(O)] CILR; (b) TGAPCR.](https://figures.cochat.ai/paper-figures/a75e073193e74b3cb7924e608d9ee943/antihypertensive-effects-of-two-novel-angiotensin-i-converting-enzyme-ace-figure-4.jpg)
![Figure 5 Molecular docking simulation of the peptides. (a,b) are local overview and two-dimensional (2D) diagram of FQIN [M(O)] CILR; (c,d) are local overview and two-dimensional (2D) diagram of TGAPCR.](https://figures.cochat.ai/paper-figures/23974cf6053d45db9a621f99f01867ea/antihypertensive-effects-of-two-novel-angiotensin-i-converting-enzyme-ace-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several bioactive peptides isolated from algal species, including Palmaria palmata [110], Gracilariopsis lemaneiformis [59], Caulerpa lentillifera (Chlorophyta) [85], Undaria pinnatifida (Phaeophyceae), Ulva rigida (Chlorophyta) [54], Chlorella [111], and Spirulina/Limnospira species [112], target the RAS and enhance nitric‐oxide production”
From Navigating the potential of algal peptides: health effects, market applications, and scientific challenges (2026) · cites this paper as [59]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Other promising peptides have been identified from Gracilariopsis lemaneiformis, Mazzaella japonica (Rhodophyta), and Ulva intestinalis (Chlorophyta), each contributing to ACE inhibition and cardiovascular health [58–60].”
From Navigating the potential of algal peptides: health effects, market applications, and scientific challenges (2026) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal structure of the human angiotensin-converting enzyme–lisinopril complex
Natesh, R., Schwager, S. L. U., Sturrock, E. D., & Acharya, K. R. (2003) · Nature · doi:10.1038/nature01370 · Cited by 888 · cited 5×
“His353, Ala354, and His513 were reported as important residues interacting with Lisinopril which formed six hydrogen bonds with ACE in the absence of the H2O molecule [3,28,41].”
BackgroundInfluentialIroyukifujita, H., Eiichiyokoyama, K., & Yoshikawa, M. (2000) · Journal of Food Science · doi:10.1111/j.1365-2621.2000.tb16049.x · Cited by 543
Molecular chaperones in cellular protein folding
Martin, J., & Hartl, F. ‐. (1994) · BioEssays · doi:10.1002/bies.950160916 · Cited by 497
Maeno, M., Yamamoto, N., & Takano, T. (1996) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(96)76487-1 · Cited by 393 · cited 1×
“There are multiple inhibition patterns of ACE inhibitory peptides: competitive inhibition, noncompetitive inhibition, and mixed-competitive inhibition [36].”
BackgroundAntihypertensive Peptides from Food Proteins
Aluko, R. E. (2015) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-022814-015520 · Cited by 383 · cited 1×
“It has been reported that ACE inhibitory peptides obtained from enzymatic, fermentative, or gastrointestinal digestion of foods exert significant antihypertensive effects in clinical and preclinical studies [12].”
BackgroundThe Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
Pacurari, M., Kafoury, R., Tchounwou, P. B., & Ndebele, K. (2014) · International Journal of Inflammation · doi:10.1155/2014/689360 · Cited by 374 · cited 1×
“Next, angiotensin I is hydrolyzed by ACE to angiotensin II, which then binds to angiotensin receptors and causes vasoconstriction [4].”
LKPNM: a prodrug-type ACE-inhibitory peptide derived from fish protein
Fujita, H., & Yoshikawa, M. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00118-6 · Cited by 372
Wijesekara, I., & Kim, S.-K. (2010) · Marine Drugs · doi:10.3390/md8041080 · Cited by 356 · cited 1×
“These short chains of amino acids are inactive within the sequence of the parent protein, but can be released during gastrointestinal digestion, food processing, or fermentation [11].”
BackgroundAlemán, A., Giménez, B., Pérez-Santin, E., Gómez-Guillén, M. C., & Montero, P. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2010.08.058 · Cited by 276
Balti, R., Bougatef, A., Sila, A., Guillochon, D., Dhulster, P., & Nedjar-Arroume, N. (2015) · Food Chemistry · doi:10.1016/j.foodchem.2013.03.091 · Cited by 206 · cited 2×
“Next, 20 μL of peptide was used to assay the ACE inhibitory activity using the above method [39].”
BackgroundMethod
Cited by
Bioactive peptides derived from marine sources: Biological and functional properties
Cunha, S. A., & Pintado, M. E. (2022) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.08.017 · Cited by 254
Red seaweed: A promising alternative protein source for global food sustainability
Rawiwan, P., Peng, Y., Paramayuda, I. G. P. B., & Quek, S. Y. (2022) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2022.03.003 · Cited by 173
Seaweeds as a Source of Functional Proteins
Thiviya, P., Gamage, A., Gama-Arachchige, N. S., Merah, O., & Madhujith, T. (2022) · Phycology · doi:10.3390/phycology2020012 · Cited by 167
Cermeño, M., Kleekayai, T., Amigo‐Benavent, M., Harnedy‐Rothwell, P., & FitzGerald, R. J. (2020) · ELECTROPHORESIS · doi:10.1002/elps.202000153 · Cited by 139
Bioactivity of Marine-Derived Peptides and Proteins: A Review
Shahidi, F., & Saeid, A. (2025) · Marine Drugs · doi:10.3390/md23040157 · Cited by 112
“This peptide effectively reduced blood pressure in spontaneously hypertensive rats [144].”
Pavlićević, M., Maestri, E., & Marmiroli, M. (2020) · Marine Drugs · doi:10.3390/md18080424 · Cited by 109
A Review on Nutrients, Phytochemicals, and Health Benefits of Green Seaweed, Caulerpa lentillifera
Syakilla, N., George, R., Chye, F. Y., Pindi, W., Mantihal, S., Wahab, N. A., Fadzwi, F. M., Gu, P. H., & Matanjun, P. (2022) · Foods · doi:10.3390/foods11182832 · Cited by 114
Liu, P., Lan, X., Muhammad, Y., Wu, S., Feng, X., Zhou, L., Sun, J., Liao, A., Liao, D., & Sun, L. (2019) · Marine Drugs · doi:10.3390/md17080463 · Cited by 73
Self-citationGuo, J., Qi, M., Chen, H., Zhou, C., Ruan, R. R., Yan, X., & Cheng, P. (2022) · Foods · doi:10.3390/foods11213455 · Cited by 60
Diagnostic and therapeutic potential of protease inhibition
Ćwilichowska, N., Świderska, K. W., Dobrzyń, A., Drąg, M., & Poręba, M. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101144 · Cited by 63
RETRACTED: In Silico identification of angiotensin-converting enzyme inhibitory peptides from MRJP1
Tahir, R. A., Bashir, A., Yousaf, M. N., Ahmed, A., Dali, Y., Khan, S., & Sehgal, S. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228265 · Cited by 53
“Additionally, the involvement of His353, Ala354, Ser355, Glu384, His513, and Pro519 residues are significant for the stability of peptide and enzyme complex while numerous effective peptides have been reported for their interactions at the specified binding sites [87, 88].”
BackgroundRetractedHuang, Y., Feng, J., Zhao, J., Hou, Y., & Hu, S. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c06053 · Cited by 46
Therapeutic Potential of Seaweed-Derived Bioactive Compounds for Cardiovascular Disease Treatment
Cho, C. H., Lu, Y., Kim, M., Jeon, Y., & Lee, S. (2022) · Applied Sciences · doi:10.3390/app12031025 · Cited by 50
Suo, Q., Yue, Y., Wang, J., Wu, N., Geng, L., & Zhang, Q. (2022) · Food & Function · doi:10.1039/d2fo01207c · Cited by 39
Self-citationJo, D., Khan, F., Park, S., Ko, S., Kim, K. W., Yang, D., Kim, J.-Y., Oh, G., Choi, G., Lee, D.-S., et al. (2024) · Marine Drugs · doi:10.3390/md22100449 · Cited by 44
Chen, J., Yu, X., Huang, W., Wang, C., & He, Q. (2021) · Food & Function · doi:10.1039/d1fo02830h · Cited by 37
Zhang, S., Han, L., Shi, Y., Li, X., Zhang, X., Hou, H., Lin, H., & Liu, K. (2018) · Marine Drugs · doi:10.3390/md16120473 · Cited by 39
“Furthermore, more hydrogen bonds were formed between YSQLENEFDR and ACE, and the number of hydrogen bonds plays a major role in determining interactions between inhibition peptides and ACE [45].”
BackgroundQian, B., Tian, C., Huo, J., Ding, Z., Xu, R., Zhu, J., Yu, L., & Villarreal, O. D. (2019) · Peptides · doi:10.1016/j.peptides.2019.170171 · Cited by 40
He, Z., Guo, L., Qiao, Z., Cao, Y., & Song, M. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.746113 · Cited by 37
Wang, S., Zhang, L., Wang, H., Liu, J., Hu, Y., & Tu, Z. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135469 · Cited by 40
Microalgae-Derived Peptides: Exploring Bioactivities and Functional Food Innovations
Ashraf, A., Guo, Y., Yang, T., ud Din, A. S., Ahmad, K., Li, W., & Hou, H. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c06800 · Cited by 32
Zhao, Y., Yin, H., Hu, C., Zeng, J., Shi, X., Chen, S., Zhang, K., Zheng, W., Wu, W., & Liu, S. (2022) · Food & Function · doi:10.1039/d1fo04239d · Cited by 32
Sutopo, C. C. Y., Sutrisno, A., Wang, L., & Hsu, J. (2020) · Process Biochemistry · doi:10.1016/j.procbio.2020.02.010 · Cited by 32
Marine-Derived Compounds Applied in Cardiovascular Diseases: Submerged Medicinal Industry
Akram, W., Rihan, M., Ahmed, S., Arora, S., Ahmad, S., & Vashishth, R. (2023) · Marine Drugs · doi:10.3390/md21030193 · Cited by 39
Seaweed Proteins: Properties, Extraction, Challenges, and Prospects
Ghelichi, S., & Jacobsen, C. (2025) · Journal of Food Science · doi:10.1111/1750-3841.70418 · Cited by 52
Structure, Function, and Therapeutic Potential of Marine Bioactive Peptides
Ovchinnikova, T. V. (2019) · Marine Drugs · doi:10.3390/md17090505 · Cited by 30
“Both peptides were noncompetitive inhibitors of ACE and reduced systolic and diastolic blood pressure in spontaneously hypertensive rats [5].”
BackgroundTargeting eukaryotic proteases for natural products-based drug development
Al‐Awadhi, F. H., & Luesch, H. (2020) · Natural Product Reports · doi:10.1039/c9np00060g · Cited by 31
Teixeira, L. M., Reis, C. P., & Pacheco, R. (2025) · Marine Drugs · doi:10.3390/md23050207 · Cited by 29
“For example, in the pharmaceutical industry, Gracilariopsis lemaneiformis peptides, such as FQIN [M(O)] CILR and TGAPCR, have demonstrated significant anti-hypertensive effects in hypertensive rat models, highlighting their therapeutic potential for blood pressure management [87].”
Du, J., Xiao, M., Sudo, N., & Liu, Q. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4183 · Cited by 30
“…Palmaria palmata , the microalga Chlorella vulgaris , Ulva intestinalis , and Gracilariopsis lemaneiformis all showed in vitro ACE inhibitory activity (Deng et al., 2018; Fitzgerald et al., 2012; Sheih, Fang, et al., 2009; Sheih, Wu, et al., 2009; Suetsuna & Nakano, 2000; Sun et al., 2019).”
BackgroundYang, G., Qin, S., & Li, W. (2021) · Journal of Food Science · doi:10.1111/1750-3841.15754 · Cited by 26
Marine Natural Products and Coronary Artery Disease
Liang, B., Cai, X., & Gu, N. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.739932 · Cited by 24
Cunha, S. A., de Castro, R., Coscueta, E. R., & Pintado, M. (2021) · Molecules · doi:10.3390/molecules26175228 · Cited by 23
“94 μM) [32] and Nannochloropsis oculata LEQ peptide (369 Da; IC50 of 173 μM) [33].”
BackgroundLiu, P., Lan, X., Muhammad, Y., Chai, K., Zhou, L., Sun, J., Lan, P., Tong, Z., Liao, D., & Sun, L. (2020) · Journal of Chromatography B · doi:10.1016/j.jchromb.2020.122042 · Cited by 23
Preparation of Antihypertensive Peptides from Quinoa Via Fermentation with Lactobacillus Paracasei
Li, S., Du, G., Shi, J., Zhang, L., Yue, T., & Yuan, Y. (2022) · eFood · doi:10.1002/efd2.20 · Cited by 24
Ejike, C. E. C. C., Ezeorba, T. P. C., Ajah, O., & Udenigwe, C. C. (2023) · Global Challenges · doi:10.1002/gch2.202200162 · Cited by 23
Visuddho, V., Halim, P., Helen, H., Muhar, A. M., Iqhrammullah, M., Mayulu, N., Surya, R., Tjandrawinata, R. R., Ribeiro, R. I. M. D. A., Tallei, T. E., et al. (2024) · Marine Drugs · doi:10.3390/md22080338 · Cited by 24
“For example, an undecapeptide derived from C. vulgaris protein waste with the sequence VECYGPNRPQF demonstrated significant dose-dependent antiproliferation and post-G1 cell cycle arrest in gastric cancer AGS cells with minimal cytotoxicity in normal lung fibroblast WI-38 cells [23].”
BackgroundDhandayuthapani, K., Malathy, S., Mulla, S. I., & Gupta, S. K. (2021) · Algae · doi:10.1007/978-981-15-7518-1_7 · Cited by 19
Loganathan, L., Gopinath, K., Sankaranarayanan, V. M., Kukreti, R., Rajendran, K., Lee, J.-K., & Muthusamy, K. (2019) · Current Drug Targets · doi:10.2174/1389450120666190808101356 · Cited by 21
Giuliani, M. E., Bigossi, G., Lai, G., Marcozzi, S., Brunetti, D., & Malavolta, M. (2024) · Marine Drugs · doi:10.3390/md22050210 · Cited by 23
Algae as a source of peptides inhibitors of the angiotensin-converting enzyme: a systematic review
de Amorim, A. P., SILVA, G. H. D., Costa, R. M. P. B., Porto, A. L. F., & Bezerra, R. P. (2022) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202220201636 · Cited by 21
Marine Natural Products in Inflammation‐Related Diseases: Opportunities and Challenges
Zhang, T., Ouyang, Z., Zhang, Y., Sun, H., Kong, L., Xu, Q., Qu, J., & Sun, Y. (2025) · Medicinal Research Reviews · doi:10.1002/med.22109 · Cited by 23
Kurniawan, R., Taslim, N. A., Hardinsyah, H., Syauki, A. Y., Idris, I., Aman, A. M., Permatasari, H. K., Wiyarta, E., Surya, R., Mayulu, N., et al. (2024) · Future Foods · doi:10.1016/j.fufo.2024.100354 · Cited by 18
Miltenburg, T. Z., da Silva, M. U., Bosch, G., & Vasconcellos, R. S. (2020) · Archives of Animal Nutrition · doi:10.1080/1745039x.2020.1849899 · Cited by 13
Köse, A. (2021) · Turkish Journal of Fisheries and Aquatic Sciences · doi:10.4194/1303-2712-v21_12_04 · Cited by 16
“Inhibition of DPP-IV enzyme is new type of therapeutic approach on the treatment of type 2 Diabetes mellitus (Deng et al., 2018).”
Bioactive Peptides from Microalgae and Cyanobacteria and Their Possible Mechanisms of Action
Chitthan, S. V., Rasheed, A. S., Muniyandi, M., Dhanasekaran, D., & Thajuddin, N. (2025) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-025-10746-7 · Cited by 12
Shannon, E., Conlon, M. A., & Hayes, M. (2023) · Journal of Applied Phycology · doi:10.1007/s10811-022-02900-1 · Cited by 12
Siddiqui, S. A., Kamran, F., Stankov, S., Rathod, N. B., Teixeira-Costa, B. E., Fidan, H., Bhat, M. I., & Sofi, S. A. (2024) · Waste and Biomass Valorization · doi:10.1007/s12649-024-02614-0 · Cited by 16
Bhoria, S., & Dhewa, T. (2025) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2025.108029 · Cited by 13
Molecular modeling in cardiovascular pharmacology: Current state of the art and perspectives
Lagoutte‐Renosi, J., Allemand, F., Ramseyer, C., Yesylevskyy, S. O., & Davani, S. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.11.026 · Cited by 12
Şensu, E., Ayar, E. N., Okudan, E. Ş., Özçelik, B., & Yücetepe, A. (2023) · ACS Omega · doi:10.1021/acsomega.3c05041 · Cited by 13
Qi, Y., Tang, X., Liu, H., Lin, Q., Lu, Y., & Luo, H. (2021) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-021-10328-3 · Cited by 8
Li, G., Yu, X., Zhan, J., Wu, C., Wu, Y., Wan, Y., Wan, W., Hu, Y., & Yang, W. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133839 · Cited by 7
Fadahunsi, O. S., Olorunnisola, O. S., Adegbola, P. I., Subair, T. I., & Elegbeleye, O. E. (2022) · In Silico Pharmacology · doi:10.1007/s40203-022-00135-z · Cited by 7
Dhaouafi, J., Romdhani, M., Deracinois, B., Flahaut, C., Balti, R., & Nedjar, N. (2024) · Waste and Biomass Valorization · doi:10.1007/s12649-024-02715-w · Cited by 7
Shen, S., Lin, S., Gao, D., Hu, J., & Bao, Z. (2025) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.70107 · Cited by 5
“47,48 Once in the bloodstream, short peptides are rapidly utilized by the body without undergoing a complex conversion process.”
Algal Proteins and Peptides: Current Trends and Future Prospects
Ganesan, A. R., Munisamy, S., Bhat, R., Seedevi, P., Mohan, K., & Matsukawa, S. (2021) · Wiley eBooks · doi:10.1002/9781119542650.ch14 · Cited by 6
Khaliq, M., Noor, Z., Moazzam, M., Saeed, F., Tul-Zohra, K., Tariq, E., Muhammad Shahbaz, H., & Khaliq, K. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2637282 · Cited by 4
“Several bioactive peptides isolated from algal species, including Palmaria palmata [110], Gracilariopsis lemaneiformis [59], Caulerpa lentillifera (Chlorophyta) [85], Undaria pinnatifida (Phaeophyceae) , Ulva rigida (Chlorophyta) [54], Chlorella [111], and Spirulina/Limnospira species [112], target…”
Alcalase for Food-Protein-Derived Bioactive Peptides: Trends, Gaps, and Translational Opportunities
Pérez‐Flores, J. G., García‐Curiel, L., Pérez-Escalante, E., Contreras‐López, E., Rodríguez-Serrano, G. M., Rivera-Arredondo, M., Ocampo, I. O. S., Sánchez-Franco, J. A., Paz‐Samaniego, R., & Guerrero-Solano, J. A. (2026) · Macromol—A Journal of Macromolecular Research · doi:10.3390/macromol6010016 · Cited by 7
“…showing low IC 50 in ACE tests and retained activity in simulated digestion; in vivo models corroborate antihypertensive effects [74,113–115,118 ,119 The MCA solution positions upstream generation (“enzymatic-hydrolysis”, “extraction”) opposite application-oriented and dairy/ACE language,…”
Araújo, T. A. D. S., de Brito, L. P., Neto, J. M. W. D., Wanderley, M. C. D. A., Albuquerque, W. W. C., Herculano, P. N., Pastrana, L. M., Cavalcanti, M. T. H., & Porto, A. L. F. (2022) · Research Society and Development · doi:10.33448/rsd-v11i11.33353 · Cited by 5
“…obtain hydrolysates and bioactive peptides which can act like drugs with anti-hypertensive activity by regulating ACE, renin and angiotensin II receptor activities, without or with reduced side-effects to human health (Aluko, 2015; Deng et al., 2018; Jahandideh et al., 2014; Jamdar et al., 2012).”
BackgroundInfluentialWindarto, S., Lee, M., Nursyam, H., & Hsu, J. (2024) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2024.103452 · Cited by 8
Mendez, R. L., Stanisheuski, S., Miranda, C. L., Stevens, J. F., & Kwon, J. Y. (2025) · International Journal of Food Science & Technology · doi:10.1093/ijfood/vvae011 · Cited by 4
Ren, R., Liu, L., Li, X., Zhang, X., Xu, M., Zhang, Z., Wang, X., Mu, B., Zhang, X., & Zhou, A. (2025) · International Dairy Journal · doi:10.1016/j.idairyj.2025.106425 · Cited by 7
Marine Origin Bioactive Peptides: Novel Advances in the Therapeutic Potential
Dehghani, M., Taherizadeh, M. R., & Homaei, A. A. (2022) · Springer eBooks · doi:10.1007/978-981-16-5374-2_11 · Cited by 5
Su, K., Ma, J., Li, Q., ZHANG, X., & Cheng, L. (2026) · Foods · doi:10.3390/foods15050811 · Cited by 7
Peptidomics as a useful tool in the follow-up of food bioactive peptides
Toldrá, F., & Mora, L. (2022) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2022.03.001 · Cited by 5
The potential of marine-derived compounds in geroscience
Giuliani, M. E., Giordani, C., Bertoni, G., Francini, E., Bigossi, G., Lai, G., Marcozzi, S., Alimi, S. S., Perini, D., Piccinini, A., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102935 · Cited by 3
Preparation of ACE inhibitory peptides from Tenebrio molitor and antibacterial activity
Sun, A., Cui, N., Zhu, Y., Zhu, N., Li, F.-M., & Sun, J. (2019) · SDRP Journal of Food Science & Technology · doi:10.25177/jfst.4.3.ra.481 · Cited by 2
Ashraf, A., Din, A. S. U., Hussain, M., Khan, I. R., Hassan, F., Ahmad, A., AL‐Ansi, W., & Lou, Z. (2023) · International Journal of Environment Agriculture and Biotechnology · doi:10.22161/ijeab.86.18 · Cited by 3
Zahroh, R., Kurniatanty, I., Sholihah, J., & Widowati, E. W. (2021) · Journal of Food and Pharmaceutical Sciences · doi:10.22146/jfps.2694 · Cited by 2
Shafie, M. H., Yap, P., & Gan, C. (2022) · Springer eBooks · doi:10.1007/978-981-19-0932-0_8 · Cited by 2
Abed, N. E., Ahmed, S. B. H., & Özoğul, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65529-6_5 · Cited by 2
Seaweed-Based Proteins and Peptides: Processing and Development of Innovative Products
Mirzapour‐Kouhdasht, A., Shaghaghian, S., & García‐Vaquero, M. (2025) · Springer eBooks · doi:10.1007/978-981-96-0519-4_9 · Cited by 1
Cardiovascular benefits of food protein-derived bioactive peptides
Aluko, R. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821389-6.00009-1 · Cited by 3
Baravia, P. A., Qhabibi, F. R., Hadinata, E., Katuuk, S. H. H., Alfaray, R. I., Rampengan, D. D. C. H., Syahputra, R. A., Taslim, N. A., Tjandrawinata, R. R., Tallei, T. E., et al. (2025) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2025.101786 · Cited by 5
Sui, Z., Hu, Y., & Chen, H. (2022) · CABI Compendium · doi:10.1079/cabicompendium.49236078 · Cited by 1
Self-citationBioactive peptides from marine sources after simulated gastrointestinal digestion
Zhang, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19141-1.00007-8
Chen, H., Wang, S., Wu, J., Chen, J., Cai, S., Xu, R., Xu, J., Zheng, L., & Zhao, M. (2026) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2026.105800 · Cited by 1
Marine metabolites as biomedical resources: innovative sea-based strategies for human health
Gaikwad, S., Trivedi, M., Tiwari, R., & Dwivedi, M. (2026) · Biomedical Materials · doi:10.1088/1748-605x/ae70e3
“Several MNPs have demonstrated potent anti-hypertensive activity, particularly through inhibition of angiotensin-converting enzyme (ACE) [34].”
Guzmán-Rodríguez, M. E., Valdez-Flores, M. A., Ayón-Fernandez, C., Ordaz-Ortíz, J. J., Guadrón‐Llanos, A. M., Magaña‐Gómez, J. A., la Herrán-Arita, A. K. D., Camberos-Barraza, J., Picos-Cárdenas, V. J., Osuna‐Ramos, J. F., et al. (2026) · Scientia Pharmaceutica · doi:10.3390/scipharm94020043
“Similarly, peptides from Gracilariopsis lemaneiformis , such as FQIN[M(O)]CILR and TGAPCR, exhibited low IC 50 values, docking interactions with ACE active pockets, gastrointestinal stability, and antihypertensive effects in spontaneously hypertensive rats [84].”
Karimi, I., Olfati, P., Yousofvand, N., Mohammed, L. J., & Schiöth, H. B. (2026) · Electronic Journal of Biotechnology · doi:10.1016/j.ejbt.2026.100728
“Antihypertensive proteins and peptides of algae are nitric oxide inhibitors, angiotensin-converting enzyme (ACE) inhibitors, I and II photosystem proteins, dipeptidyl peptidase IV inhibitory peptide, and different dipeptides [5,10,11,14,16,18,19,20,21,22,23,24, 25,26,27,28,29,30,31,32,33,34].”
Sathsarani, N. A. S. N., Yim, M., Wijerathne, H. D. T. U., Herath, K. H. I. N. M., Lee, J. M., Sanjeewa, K. K. A., & Kim, H.-S. (2026) · Pharmaceuticals · doi:10.3390/ph19101533
Metadata
- Authors
- Deng, Z., Liu, Y., Wang, J., Wu, S., Geng, L., Sui, Z., & Zhang, Q.
- Affiliations
- Chinese Academy of Sciences (CN)
- Ocean University of China (CN)
- Corresponding author
- Sui, Zhenghong
- Zhang, Quanbin
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2018-08-27
- Volume
- 16
- Issue
- 9
- Pages
- 299
- ISSN
- 1660-3397 (ISSN-L)
- PMC
- PMC6163600
- OpenAlex
- W2889338605
- Cited by
- 81
- References
- 49
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 13 · 2023: 5 · 2022: 15 · 2021: 13 · 2020: 8 · 2019: 5 · 2018: 1
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Marine Drugs (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Youth Innovation Promotion Association of the Chinese Academy of Sciences (2016190)
- the Key Research and Development Project of Shandong Province (2016YYSP002)
- Fujian STS project of Chinese Academy of Science (2017T3015)
- the Science and Technology project of Fujian Province (2017T3013)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Protein Hydrolysis and Bioactive Peptides
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- angiotensin I-converting enzyme inhibitory peptides, Gracilaria lemaneiformis, red algae, protein hydrolysates, antihypertensive effect, spontaneously hypertensive rats, blood pressure reduction, peptide stability, non-competitive inhibition, molecular docking
- MeSH terms
- Administration, Oral, Rhodophyta, Angiotensin-Converting Enzyme Inhibitors, Animals, Antihypertensive Agents, Biological Products, Blood Pressure, Disease Models, Animal, Drug Evaluation, Preclinical, Humans, Hypertension, Peptidyl-Dipeptidase A, Male, Peptides, Protein Hydrolysates, Rats, Inbred SHR, Rats, Tandem Mass Spectrometry, Molecular Docking Simulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.